The notion “hepatitis” means inflammation of the liver or its cells, often caused by some virus and accompanied in its initial phase to by symptoms similar to flu: fever, loss of appetite, muscle/joint aches, etc. According to the virus type hepatitis is divided into several types: hepatitis A, В C, D and E. Hepatitis can disappear on its own, but in some cases it can lead to serious liver dysfunctions and severe complications such as fibrosis, liver failure or cancer, cryoglobulinemia, an a lot more.
The world hepatitis drugs market has experienced stable growth over the recent years, driven by the constant increase of demand from developed countries, introduction of new products and technological advancement in the medical industry. It is set to continue growing at a CARG of above 12% through 2015. Gilead Sciences, Merck & Co., GlaxoSmithKline, Bristol-Myers Squibb and Hoffmann-La Roche are amid the key hepatitis market players.
The collection of the research reports found in this catalogue provides an extensive insight into the hepatitis market at different geographical scales. Relevant information on the market size, share, segmentation as well as major factors influencing the market is presented in the researches. The reports offer detailed assessment of the competitive landscape and profile top companies. In addition, discussions of future market prospects for the are at hand in the research reports.
Publications found:
152
Sort by:
2017 Italy Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals-Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,120.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
November 2016
241 pages
2017 Japan Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals-Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,120.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
November 2016
241 pages
2017 France Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals-Supplier Shares and Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,120.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
November 2016
241 pages
2017 Spain Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals-Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,120.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
November 2016
241 pages
2017 US Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs-Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,120.00
... report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
November 2016
241 pages
2017 World Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs-Supplier Shares and Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 4,360.00
... , Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides ... NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
November 2016
320 pages
Hepatitis C: KOL Insight
US$ 7,900.00
... options? Since the launch of Sovaldi (sofosbuvir; Gilead) in 2013, the hepatitis C (HCV) landscape has developed at a rapid pace. The focus has ... report reveals candid insights about the HCV landscape from 12 KOLs in North America and Europe. You’ll learn which treatments KOLs have confidence ... advantage. Update Bulletins include expert insight and analysis based on FirstWord analyst re-engagement with the KOLs after major events such as product ...
August 2016
Global Hepatitis C Virus (HCV) Market Report: 2016 Edition
US$ 800.00
Hepatitis C Virus (HCV) is an infection which affects the liver which may ... The key factors which are anticipated to drive HCV market include medical reimbursement because of the therapy ... are analyzed in depth. On the contention front, the global HCV market is reined by few major players namely Gilead Sciences, ...
February 2016
60 pages
Hepatitis C: Update Bulletin [February 2016]
US$ 995.00
... on the latest events that have the potential to shape the hepatitis C virus (HCV) treatment landscape. Topics covered include KOL ... if a short treatment regimen is attractive to KOLs. Key Questions Answered in this Update Bulletin: How do KOLs expect Merck & Co.’s Zepatier (elbasvir and grazoprevir) to be ...
January 2016
2016 Europe Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices - Supplier Shares and Country Sales Segment Forecasts for 10 Immunodiagnostic and NAT Procedures
US$ 5,520.00
... $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology ...
November 2015
295 pages
2016 Future Horizons and Growth Strategies in the World Hepatitis Diagnostic Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 7,600.00
The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country ...
November 2015
320 pages
2016 Europe Hepatitis Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Suppliers
US$ 5,520.00
... report $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are ...
October 2015
295 pages
2016 Europe HIV/AIDS Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Suppliers
US$ 3,160.00
... . DataPack (test volumes, sales forecasts, supplier shares) $2,500. Summary This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV -1/2/Combo, HIVAg/HIV ...
October 2015
277 pages
2016 Emerging Opportunities in the German Hepatitis Diagnostic Testing Market
US$ 3,120.00
... report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology ... innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry ...
October 2015
241 pages
2016 Emerging Opportunities in the Italian Hepatitis Diagnostic Testing Market
US$ 3,120.00
... report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology ... innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry ...
October 2015
241 pages
2016 Emerging Opportunities in the Japanese Hepatitis Diagnostic Testing Market
US$ 3,120.00
... report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology ... innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry ...
October 2015
241 pages
2016 Emerging Opportunities in the Spanish Hepatitis Diagnostic Testing Market
US$ 3,120.00
... report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology ... innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry ...
October 2015
241 pages
Global Human Hepatitis B Immunoglobulin Industry 2015 Market Research Report
US$ 2,850.00
2015 Global Human Hepatitis B Immunoglobulin Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Human Hepatitis B Immunoglobulin industry, focusing on the ... with: 1.) basic information; 2.) the Asia Human Hepatitis B Immunoglobulin industry; 3.) the North American Human Hepatitis B Immunoglobulin industry; 4.) the European Human Hepatitis B Immunoglobulin industry; 5.) market entry and investment feasibility ...
October 2015
167 pages
2015 Europe Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Public Health Labs - Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 5,520.00
... presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
October 2015
295 pages
2015-2019 Europe Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices - Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
US$ 5,520.00
... $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology ...
September 2015
295 pages
2015-2019 Global Hepatitis Markers Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers - France, Germany, Italy, Japan, Spain, UK, US
US$ 7,600.00
... , Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals - Commercial ... , in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the ...
September 2015
320 pages
2015-2019 World Hepatitis Markers Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers - France, Germany, Italy, Japan, Spain, UK, US
US$ 7,600.00
... , Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: Hospitals Commercial ... , in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the ...
June 2015
295 pages
2015-2019 European Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices - Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
US$ 5,520.00
... $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology ...
June 2015
295 pages
